文献速递生殖医学

接受体外受精治疗并诊断为细菌性阴道病或阴道菌群异常的患者的生殖结局:一项系统性PRISMA综述与荟萃分析

Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis.
PubMed 文献 · BJOG · 2018-03-25

该系统性综述与荟萃分析纳入12项研究共2980例接受体外受精的不孕女性,评估细菌性阴道病或阴道菌群异常与生殖结局的关联。细菌性阴道病患病率为16%(95%CI 15-18%),与早期自然流产相关(RR 1.68,95%CI 1.24-2.27),但与活产率(RR 1.47,95%CI 0.96-1.57)和临床妊娠率(RR 0.93,95%CI 0.75-1.15)无显著关联。作者认为证据质量极低,结果不明确,需进一步研究。

要点

  • 细菌性阴道病与输卵管因素不孕相关(P=0.001),患病率16%(95%CI 15-18%)。
  • 细菌性阴道病与早期自然流产相关(RR 1.68,95%CI 1.24-2.27)。
  • 细菌性阴道病与活产率(RR 1.47,95%CI 0.96-1.57)和临床妊娠率(RR 0.93,95%CI 0.75-1.15)无显著关联。

核心结论

  • 细菌性阴道病与输卵管因素不孕和早期自然流产相关,但证据质量极低,结果不明确,需进一步研究。

研究设计与样本

  • 系统性PRISMA综述与荟萃分析,纳入12项研究共2980例接受体外受精治疗的不孕女性。

主要发现

  • 细菌性阴道病患病率为16%(95%CI 15-18%)。
  • 输卵管因素不孕在细菌性阴道病患者中较阴道菌群正常患者更常见(P=0.001)。
  • 细菌性阴道病与早期自然流产相关(RR 1.68,95%CI 1.24-2.27)。
  • 细菌性阴道病与活产率无显著关联(RR 1.47,95%CI 0.96-1.57)。
  • 细菌性阴道病与临床妊娠率无显著关联(RR 0.93,95%CI 0.75-1.15)。

关键数值与推荐

  • 纳入标准:人群为接受体外受精治疗的不孕女性,暴露为细菌性阴道病或阴道菌群异常,结局包括活产率、早期自然流产率和临床妊娠率。
  • 采用GRADE证据评估对上述结局进行证据质量评价。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 证据质量极低。
  • 结果不明确,需进一步研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Despite recent efforts, the risks associated with bacterial vaginosis (BV) or abnormal vaginal microbiota in IVF patients are not well-established. OBJECTIVES: We aimed to evaluate the risks associated with BV in IVF patients using meta-analysis. SEARCH STRATEGY: Following preliminary searches to find relevant keywords and MeSH terms, a systematic search was performed in PubMed (MEDLINE) in September 2017. SELECTION CRITERIA: The population was infertile women attending IVF treatment. The exposure was BV or abnormal vaginal microbiota. Outcomes included live birth rate, early spontaneous abortion rate and clinical pregnancy rate. DATA COLLECTION AND ANALYSIS: Data were collected for each study and for each outcome using a summary of findings table. If appropriate, data were quantitatively assessed using meta-analysis, sensitivity analysis, funnel plots and GRADE evidence assessment were performed for the above-mentioned outcomes. MAIN RESULTS: A total of 12 studies were eligible, comprising a total of 2980 patients. The prevalence of BV was 16% (95% CI 15-18%) in the general study population and tubal factor infertility was highly prevalent in patients diagnosed with BV compared with normal vaginal microbiota patients (P = 0.001). Despite a significant association with early spontaneous abortion [relative risk (RR) 1.68, 95% CI 1.24-2.27], BV did not significantly impact the live birth rate (RR 1.47, 95% CI 0.96-1.57) or the clinical pregnancy rate (RR 0.93, 95% CI 0.75-1.15). CONCLUSIONS: BV is associated with tubal factor infertility and early spontaneous abortion. However, the quality of evidence was very low and the equivocal results justify the need for further research. TWEETABLE ABSTRACT: Abnormal vaginal microbiota is associated with early spontaneous abortion in IVF patients.

来源:BJOG,查看原文。版权归原作者所有。

引用

  1. Haahr T, Zacho J, Bräuner M, et al. Reproductive outcome of patients undergoing in vitro fertilisation treatment and diagnosed with bacterial vaginosis or abnormal vaginal microbiota: a systematic PRISMA review and meta-analysis. BJOG. 2018. PMID: 29469992. doi:10.1111/1471-0528.15178

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。